An assessment of the likely acceptability of vaginal microbicides for HIV prevention among women in rural Ghana.
Identifieur interne : 000477 ( PubMed/Checkpoint ); précédent : 000476; suivant : 000478An assessment of the likely acceptability of vaginal microbicides for HIV prevention among women in rural Ghana.
Auteurs : Martha A. Abdulai [Ghana] ; Frank Baiden ; George Adjei ; Samuel Afari-Asiedu ; Kwame Adjei ; Charlotte Tawiah ; Sam NewtonSource :
- BMC women's health [ 1472-6874 ] ; 2012.
Descripteurs français
- KwdFr :
- Acceptation des soins par le patient (), Administration par voie vaginale, Adulte, Anti-infectieux (usage thérapeutique), Comportement en matière de santé, Crèmes, mousses et gels vaginaux (usage thérapeutique), Femelle, Ghana (épidémiologie), Humains, Infections à VIH (), Infections à VIH (traitement médicamenteux), Intervalles de confiance, Jeune adulte, Modèles logistiques, Odds ratio, Population rurale (), Vagin (), Études transversales.
- MESH :
- traitement médicamenteux : Infections à VIH.
- usage thérapeutique : Anti-infectieux, Crèmes, mousses et gels vaginaux.
- épidémiologie : Ghana.
- Acceptation des soins par le patient, Administration par voie vaginale, Adulte, Comportement en matière de santé, Femelle, Humains, Infections à VIH, Intervalles de confiance, Jeune adulte, Modèles logistiques, Odds ratio, Population rurale, Vagin, Études transversales.
- Wicri :
- geographic : Ghana.
English descriptors
- KwdEn :
- Administration, Intravaginal, Adult, Anti-Infective Agents (therapeutic use), Confidence Intervals, Cross-Sectional Studies, Female, Ghana (epidemiology), HIV Infections (drug therapy), HIV Infections (prevention & control), Health Behavior, Humans, Logistic Models, Odds Ratio, Patient Acceptance of Health Care (statistics & numerical data), Rural Population (statistics & numerical data), Vagina (drug effects), Vaginal Creams, Foams, and Jellies (therapeutic use), Young Adult.
- MESH :
- chemical , therapeutic use : Anti-Infective Agents, Vaginal Creams, Foams, and Jellies.
- geographic , epidemiology : Ghana.
- drug effects : Vagina.
- drug therapy : HIV Infections.
- prevention & control : HIV Infections.
- statistics & numerical data : Patient Acceptance of Health Care, Rural Population.
- Administration, Intravaginal, Adult, Confidence Intervals, Cross-Sectional Studies, Female, Health Behavior, Humans, Logistic Models, Odds Ratio, Young Adult.
Abstract
The findings of the CAPRISA tenofovir studies have raised expectations that soon an approved microbicide would be available. However it is in only a limited number of countries in sub-Saharan Africa that the acceptability of microbicides has been evaluated. We conducted a study to assess the acceptability of vaginal microbicides among women in rural Ghana.
DOI: 10.1186/1472-6874-12-40
PubMed: 23114222
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:23114222Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">An assessment of the likely acceptability of vaginal microbicides for HIV prevention among women in rural Ghana.</title><author><name sortKey="Abdulai, Martha A" sort="Abdulai, Martha A" uniqKey="Abdulai M" first="Martha A" last="Abdulai">Martha A. Abdulai</name><affiliation wicri:level="1"><nlm:affiliation>Kintampo Health Research Centre, P. O. Box 200, Kintampo, Ghana. molmart2000@yahoo.com</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Kintampo Health Research Centre, P. O. Box 200, Kintampo</wicri:regionArea><wicri:noRegion>Kintampo</wicri:noRegion></affiliation></author><author><name sortKey="Baiden, Frank" sort="Baiden, Frank" uniqKey="Baiden F" first="Frank" last="Baiden">Frank Baiden</name></author><author><name sortKey="Adjei, George" sort="Adjei, George" uniqKey="Adjei G" first="George" last="Adjei">George Adjei</name></author><author><name sortKey="Afari Asiedu, Samuel" sort="Afari Asiedu, Samuel" uniqKey="Afari Asiedu S" first="Samuel" last="Afari-Asiedu">Samuel Afari-Asiedu</name></author><author><name sortKey="Adjei, Kwame" sort="Adjei, Kwame" uniqKey="Adjei K" first="Kwame" last="Adjei">Kwame Adjei</name></author><author><name sortKey="Tawiah, Charlotte" sort="Tawiah, Charlotte" uniqKey="Tawiah C" first="Charlotte" last="Tawiah">Charlotte Tawiah</name></author><author><name sortKey="Newton, Sam" sort="Newton, Sam" uniqKey="Newton S" first="Sam" last="Newton">Sam Newton</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:23114222</idno><idno type="pmid">23114222</idno><idno type="doi">10.1186/1472-6874-12-40</idno><idno type="wicri:Area/PubMed/Corpus">000156</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000156</idno><idno type="wicri:Area/PubMed/Curation">000156</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000156</idno><idno type="wicri:Area/PubMed/Checkpoint">000156</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000156</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">An assessment of the likely acceptability of vaginal microbicides for HIV prevention among women in rural Ghana.</title><author><name sortKey="Abdulai, Martha A" sort="Abdulai, Martha A" uniqKey="Abdulai M" first="Martha A" last="Abdulai">Martha A. Abdulai</name><affiliation wicri:level="1"><nlm:affiliation>Kintampo Health Research Centre, P. O. Box 200, Kintampo, Ghana. molmart2000@yahoo.com</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Kintampo Health Research Centre, P. O. Box 200, Kintampo</wicri:regionArea><wicri:noRegion>Kintampo</wicri:noRegion></affiliation></author><author><name sortKey="Baiden, Frank" sort="Baiden, Frank" uniqKey="Baiden F" first="Frank" last="Baiden">Frank Baiden</name></author><author><name sortKey="Adjei, George" sort="Adjei, George" uniqKey="Adjei G" first="George" last="Adjei">George Adjei</name></author><author><name sortKey="Afari Asiedu, Samuel" sort="Afari Asiedu, Samuel" uniqKey="Afari Asiedu S" first="Samuel" last="Afari-Asiedu">Samuel Afari-Asiedu</name></author><author><name sortKey="Adjei, Kwame" sort="Adjei, Kwame" uniqKey="Adjei K" first="Kwame" last="Adjei">Kwame Adjei</name></author><author><name sortKey="Tawiah, Charlotte" sort="Tawiah, Charlotte" uniqKey="Tawiah C" first="Charlotte" last="Tawiah">Charlotte Tawiah</name></author><author><name sortKey="Newton, Sam" sort="Newton, Sam" uniqKey="Newton S" first="Sam" last="Newton">Sam Newton</name></author></analytic><series><title level="j">BMC women's health</title><idno type="eISSN">1472-6874</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Intravaginal</term><term>Adult</term><term>Anti-Infective Agents (therapeutic use)</term><term>Confidence Intervals</term><term>Cross-Sectional Studies</term><term>Female</term><term>Ghana (epidemiology)</term><term>HIV Infections (drug therapy)</term><term>HIV Infections (prevention & control)</term><term>Health Behavior</term><term>Humans</term><term>Logistic Models</term><term>Odds Ratio</term><term>Patient Acceptance of Health Care (statistics & numerical data)</term><term>Rural Population (statistics & numerical data)</term><term>Vagina (drug effects)</term><term>Vaginal Creams, Foams, and Jellies (therapeutic use)</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Acceptation des soins par le patient ()</term><term>Administration par voie vaginale</term><term>Adulte</term><term>Anti-infectieux (usage thérapeutique)</term><term>Comportement en matière de santé</term><term>Crèmes, mousses et gels vaginaux (usage thérapeutique)</term><term>Femelle</term><term>Ghana (épidémiologie)</term><term>Humains</term><term>Infections à VIH ()</term><term>Infections à VIH (traitement médicamenteux)</term><term>Intervalles de confiance</term><term>Jeune adulte</term><term>Modèles logistiques</term><term>Odds ratio</term><term>Population rurale ()</term><term>Vagin ()</term><term>Études transversales</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Infective Agents</term><term>Vaginal Creams, Foams, and Jellies</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Ghana</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Vagina</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Patient Acceptance of Health Care</term><term>Rural Population</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anti-infectieux</term><term>Crèmes, mousses et gels vaginaux</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Ghana</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Administration, Intravaginal</term><term>Adult</term><term>Confidence Intervals</term><term>Cross-Sectional Studies</term><term>Female</term><term>Health Behavior</term><term>Humans</term><term>Logistic Models</term><term>Odds Ratio</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Acceptation des soins par le patient</term><term>Administration par voie vaginale</term><term>Adulte</term><term>Comportement en matière de santé</term><term>Femelle</term><term>Humains</term><term>Infections à VIH</term><term>Intervalles de confiance</term><term>Jeune adulte</term><term>Modèles logistiques</term><term>Odds ratio</term><term>Population rurale</term><term>Vagin</term><term>Études transversales</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Ghana</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The findings of the CAPRISA tenofovir studies have raised expectations that soon an approved microbicide would be available. However it is in only a limited number of countries in sub-Saharan Africa that the acceptability of microbicides has been evaluated. We conducted a study to assess the acceptability of vaginal microbicides among women in rural Ghana.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23114222</PMID><DateCreated><Year>2012</Year><Month>12</Month><Day>11</Day></DateCreated><DateCompleted><Year>2013</Year><Month>06</Month><Day>28</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6874</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2012</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>BMC women's health</Title><ISOAbbreviation>BMC Womens Health</ISOAbbreviation></Journal><ArticleTitle>An assessment of the likely acceptability of vaginal microbicides for HIV prevention among women in rural Ghana.</ArticleTitle><Pagination><MedlinePgn>40</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1472-6874-12-40</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The findings of the CAPRISA tenofovir studies have raised expectations that soon an approved microbicide would be available. However it is in only a limited number of countries in sub-Saharan Africa that the acceptability of microbicides has been evaluated. We conducted a study to assess the acceptability of vaginal microbicides among women in rural Ghana.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study employs a mixed method design, using cross-sectional survey and focus group discussions to further understand issues related to awareness and attitudes towards microbicide development, acceptability and perceived partner attitudes among pregnant women attending antenatal clinic in two health facilities in the Kintampo North municipality of Ghana. We used logistic regression to identify possible predictors of microbicide acceptability among the women surveyed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Although only 2% of the 504 women were aware of the development of microbicides, 95% were willing to use one when it became available. The cost of a microbicide that will be considered affordable to 50% of women was US$0.75. Although there were concerns about possible wetting effect, gel or creams were the most preferred (68% of women) formulation. Although 71% thought their partners will find microbicide acceptable, apprehensions about the feasibility of and consequences of failed discreet use were evident. 49% of women were concerned about possible negative effect of microbicide on sexual pleasure. Perceived partner acceptability (O.R. =17.7; 95%C.I. 5.03-62.5) and possibility of discreet use (O.R. =8.9 95%C.I. 2.63-30.13) were the important predictors of microbicide acceptability.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Achieving microbicide acceptability among male partners should be made a part of the promotive interventions for ensuring effective use among women in rural Ghana.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abdulai</LastName><ForeName>Martha A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Kintampo Health Research Centre, P. O. Box 200, Kintampo, Ghana. molmart2000@yahoo.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baiden</LastName><ForeName>Frank</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Adjei</LastName><ForeName>George</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Afari-Asiedu</LastName><ForeName>Samuel</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Adjei</LastName><ForeName>Kwame</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Tawiah</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Newton</LastName><ForeName>Sam</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>11</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Womens Health</MedlineTA><NlmUniqueID>101088690</NlmUniqueID><ISSNLinking>1472-6874</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000890">Anti-Infective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014622">Vaginal Creams, Foams, and Jellies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):207-10</RefSource><PMID Version="1">21654503</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2012 Oct 1;206(7):993-1001</RefSource><PMID Version="1">22829639</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Behav. 2008 Mar;12(2):272-83</RefSource><PMID Version="1">17592763</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Anal Afr. 1995 Aug;5(4):8-9</RefSource><PMID Version="1">12289858</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Soc Sci Med. 2001 Feb;52(4):585-98</RefSource><PMID Version="1">11206655</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Behav. 2012 Oct;16(7):1775-86</RefSource><PMID Version="1">22644068</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Care. 2008 Aug;20(7):853-62</RefSource><PMID Version="1">18608053</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Infect Dis. 2012 Feb;25(1):51-7</RefSource><PMID Version="1">22156901</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sex Transm Infect. 2010 Jun;86(3):212-6</RefSource><PMID Version="1">20522634</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2010 Sep 3;329(5996):1168-74</RefSource><PMID Version="1">20643915</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cold Spring Harb Perspect Med. 2012 Feb;2(2):a007385</RefSource><PMID Version="1">22355798</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Soc Issues. 2005 Mar;61(1):67-93</RefSource><PMID Version="1">21822334</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):e23-8</RefSource><PMID Version="1">21694607</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2008 Aug;22 Suppl 2:S5-8</RefSource><PMID Version="1">18641471</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Womens Health (Larchmt). 2010 Apr;19(4):791-8</RefSource><PMID Version="1">20210540</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Educ Prev. 2008 Apr;20(2):171-87</RefSource><PMID Version="1">18433322</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Collegian. 2012;19(1):23-32</RefSource><PMID Version="1">22482279</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ethn Health. 2011 Apr;16(2):89-106</RefSource><PMID Version="1">21328113</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Indian J Med Res. 2010 Dec;132:656-9</RefSource><PMID Version="1">21245610</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin HIV AIDS. 2009 Jul;4(4):240-6</RefSource><PMID Version="1">19532059</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Pharm Des. 2004;10(3):315-36</RefSource><PMID Version="1">14754390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Soc Sci Med. 2005 Jan;60(2):319-30</RefSource><PMID Version="1">15522488</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2000 Mar 31;14(5):537-46</RefSource><PMID Version="1">10780716</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>SAHARA J. 2008 Apr;5(1):11-8</RefSource><PMID Version="1">18496615</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Future Microbiol. 2011 Jul;6(7):731-7</RefSource><PMID Version="1">21797688</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Afr J Reprod Health. 2009 Mar;13(1):61-78</RefSource><PMID Version="1">20687266</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 1998 Jul 30;12(11):1389-91</RefSource><PMID Version="1">9708420</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cult Health Sex. 2010 Oct;12(7):739-54</RefSource><PMID Version="1">20397080</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2010 Jul 9;329(5988):145-7</RefSource><PMID Version="1">20616253</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Infect Dis. 2008 Nov;8(11):685-97</RefSource><PMID Version="1">18992405</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trials. 2011;12:67</RefSource><PMID Version="1">21385354</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Fam Plann Perspect. 1999 Jan-Feb;31(1):16-23</RefSource><PMID Version="1">10029928</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Drug Deliv Transl Res. 2011 Jun;1(3):194-200</RefSource><PMID Version="1">21766050</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Sex Behav. 2010 Jun;39(3):748-60</RefSource><PMID Version="1">19636696</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2006 Aug 5;368(9534):431-3</RefSource><PMID Version="1">16890813</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Psychol Bull. 2002 Nov;128(6):851-85</RefSource><PMID Version="1">12405135</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>West Indian Med J. 2009 Jun;58(3):277-82</RefSource><PMID Version="1">20043539</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Care. 2008 Jul;20(6):733-40</RefSource><PMID Version="1">18576176</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000282" MajorTopicYN="N">Administration, Intravaginal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000890" MajorTopicYN="N">Anti-Infective Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016001" MajorTopicYN="N">Confidence Intervals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005869" MajorTopicYN="N" Type="Geographic">Ghana</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015438" MajorTopicYN="Y">Health Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010342" MajorTopicYN="N">Patient Acceptance of Health Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012424" MajorTopicYN="N">Rural Population</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014621" MajorTopicYN="N">Vagina</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014622" MajorTopicYN="N">Vaginal Creams, Foams, and Jellies</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC3519568</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23114222</ArticleId><ArticleId IdType="pii">1472-6874-12-40</ArticleId><ArticleId IdType="doi">10.1186/1472-6874-12-40</ArticleId><ArticleId IdType="pmc">PMC3519568</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Ghana</li></country></list><tree><noCountry><name sortKey="Adjei, George" sort="Adjei, George" uniqKey="Adjei G" first="George" last="Adjei">George Adjei</name><name sortKey="Adjei, Kwame" sort="Adjei, Kwame" uniqKey="Adjei K" first="Kwame" last="Adjei">Kwame Adjei</name><name sortKey="Afari Asiedu, Samuel" sort="Afari Asiedu, Samuel" uniqKey="Afari Asiedu S" first="Samuel" last="Afari-Asiedu">Samuel Afari-Asiedu</name><name sortKey="Baiden, Frank" sort="Baiden, Frank" uniqKey="Baiden F" first="Frank" last="Baiden">Frank Baiden</name><name sortKey="Newton, Sam" sort="Newton, Sam" uniqKey="Newton S" first="Sam" last="Newton">Sam Newton</name><name sortKey="Tawiah, Charlotte" sort="Tawiah, Charlotte" uniqKey="Tawiah C" first="Charlotte" last="Tawiah">Charlotte Tawiah</name></noCountry><country name="Ghana"><noRegion><name sortKey="Abdulai, Martha A" sort="Abdulai, Martha A" uniqKey="Abdulai M" first="Martha A" last="Abdulai">Martha A. Abdulai</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000477 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000477 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:23114222
|texte= An assessment of the likely acceptability of vaginal microbicides for HIV prevention among women in rural Ghana.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:23114222" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |